This observation raises the possibility that hyperkalemia may prevent the development of hypertension in FHHt until a second hit disrupts hyperkalemic PP1 activation, allowing the gain-of-function mutations in WNK signaling to fully manifest in maximal NCC phosphorylation. The gene discussed is SLC12A3; the disease is Hyperkalemia.